INS and type 2 diabetes mellitus: This impairment leads to a reduction in insulin secretion, which is insufficient to meet the body’s requirements for glycemic control, thereby exacerbating hyperglycemia and contributing to the pathogenesis of type 2 diabetes mellitus.